0000899243-18-007529.txt : 20180315 0000899243-18-007529.hdr.sgml : 20180315 20180315160527 ACCESSION NUMBER: 0000899243-18-007529 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180314 FILED AS OF DATE: 20180315 DATE AS OF CHANGE: 20180315 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Gengos Andrew CENTRAL INDEX KEY: 0001563623 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37566 FILM NUMBER: 18692400 MAIL ADDRESS: STREET 1: 21900 BURBANK BOULEVARD STREET 2: 3RD FLOOR CITY: WOODLAND HILLS STATE: CA ZIP: 91367 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: SYNLOGIC, INC. CENTRAL INDEX KEY: 0001527599 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 261824804 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 301 BINNEY STREET STREET 2: SUITE 402 CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: 617-401-9975 MAIL ADDRESS: STREET 1: 301 BINNEY STREET STREET 2: SUITE 402 CITY: CAMBRIDGE STATE: MA ZIP: 02142 FORMER COMPANY: FORMER CONFORMED NAME: Mirna Therapeutics, Inc. DATE OF NAME CHANGE: 20110809 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2018-03-14 0 0001527599 SYNLOGIC, INC. SYBX 0001563623 Gengos Andrew C/O SYNLOGIC, INC. 301 BINNEY STREET, SUITE 402 CAMBRIDGE MA 02142 0 1 0 0 Chief Operating Officer Stock Option (right to buy) 9.95 2018-03-14 4 A 0 10000 0.00 A 2028-03-14 Common Stock 10000 10000 D The options vest and become exercisable in substantially equal monthly installments beginning on April 14, 2018 and continuing until March 14, 2022, subject to the Reporting Person continuing to provide services to the Issuer through each such vesting date. /s/ William J. Bussiere, Jr., Attorney-in-fact 2018-03-15